Other Clinical Trial - Efficacy Study of Pharmacist Intervention on

Status Recruiting

Clinical Trial Summary

The investigators propose that pharmacist interventions would reduce the amount of unresolved medication-related problems in hemodialysis patients.

Condition:Hemodialysis patients

Intervention:Behavioral,Pharmacist intervention

Study Design:Randomized Allocation

Control: Active Control

Endpoint Classification: Efficacy Study

Intervention Model: Parallel Assignment

Masking: Double Blind (Caregiver, Outcomes Assessor)

Primary Purpose: Treatment

Clinical Trial Description

Introduction:

End stage renal disease (ESRD) incidence in Taiwan ranked first and prevalence ranked second in the world from 2002 to 2005. Several foreign researches had reported that hemodialysis (HD) patients often require 12 medications to treat 5 to 6 comorbid conditions. Besides, ESRD is a lifelong disease and rates of compliance may diminish overtime. Thus, HD patients may be at particular risk for drug related problems, durg-drug interactions and noncompliance. Our aim is to analysis the effect of pharmacist in medication-related problems in ambulatory hemodialysis patients.

Methods:

This study is a randomized double-blind, active controlled trial. The investigators will invite and communicate with HD patients to find medication -related problems. After pharmacist evaluation, pharmacist will do pharmaceutical interventions to resolve medication-related problems, drug-drug interactions etc. in experimental group. In the active control group, pharmacist in this study will not do pharmaceutical interventions. The investigators will monitor each patient in a two-week period for medication-related problems.

Our primary outcome is the amount of unresolved medication-related problems in each group after two weeks. Blind outcome assessor will evaluate the amount of unresolved medication-related problems in each case as well as compliance in these patients after two weeks.

The investigators suppose that clinical pharmaceutical intervention will reduce the amount of unresolved medication-related problem in experimental group. On the other hand, patients without clinical pharmaceutical intervention will have more unresolved medication-related problems. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Kidney Failure, Chronic
Renal Failure Chronic Requiring Hemodialysis

Clinical Trial Details

NCT number	NCT01356563
Study type	Interventional
Source	Sin-Lau Hospital
Contact
Status	Recruiting
Phase	N/A
Start date	May 2011
Completion date	May 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01947673` - Mechanisms of Intradialytic Hypertension	N/A
Not yet recruiting	`NCT03634904` - Serum Ceftazidime Concentrations in Hemodialysis Patients	N/A
Terminated	`NCT01982864` - Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.	Phase 4
Completed	`NCT01421771` - Blood Pressure in Dialysis Patients	N/A
Completed	`NCT01448174` - Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients	Phase 4
Completed	`NCT01722695` - Performance Comparison of Revaclear With Larger Dialyzer	N/A
Withdrawn	`NCT01015313` - Effects of Intensified Sodium Management in Hemodialysis Patients	N/A
Completed	`NCT02259413` - Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis	N/A
Not yet recruiting	`NCT02452788` - Pharmaceutical Care in Ambulatory Hemodialysis Patients	N/A
Completed	`NCT01181544` - A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis	N/A
Completed	`NCT01320202` - Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients	Phase 3
Completed	`NCT02285075` - Temocillin Pharmacokinetic in Hemodialysis	Phase 4
Completed	`NCT02825589` - BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients	N/A
Completed	`NCT00890045` - Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study	N/A
Not yet recruiting	`NCT02264964` - Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis	N/A
Completed	`NCT01214928` - Hemodialysis Vitamin D Pilot	N/A
Terminated	`NCT01312441` - Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D	Phase 4
Completed	`NCT00967993` - Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease	Phase 2
Completed	`NCT01981603` - Transplant Navigator Dissemination	N/A
Completed	`NCT01578421` - Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms